We are live on ! Find out more
DICE

DICE Therapeutics, Inc. Common Stock

Delisted

DICE was delisted on the 8th of August, 2023.

0 hedge funds and large institutions have $0 invested in DICE Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 159 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1600 (-160)

100% less funds holding in top 10

Funds holding in top 10: 100 (-10)

100% less capital invested

Capital invested by funds: $2.11B → $0 (-$2.11B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 159

Holders
Holders Change
-160
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
159
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SGCM
26
Sand Grove Capital Management
United Kingdom
-$19.6M -422,359 Closed
NIP
27
Nicholas Investment Partners
California
-$19.3M -416,151 Closed
ACH
28
ArrowMark Colorado Holdings
Colorado
-$19.1M -410,797 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
29
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$18.7M -403,000 Closed
UBS Group
30
UBS Group
Switzerland
-$18.6M -399,284 Closed
NLVP
31
New Leaf Venture Partners
New York
-$17.3M -371,693 Closed
PMAM
32
Picton Mahoney Asset Management
Ontario, Canada
-$17.2M -370,000 Closed
HSBC Holdings
33
HSBC Holdings
United Kingdom
-$17M -367,131 Closed
Northern Trust
34
Northern Trust
Illinois
-$16.1M -346,261 Closed
AA
35
AQR Arbitrage
Connecticut
-$15.9M -341,883 Closed
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
-$15M -323,453 Closed
OMC
37
OUP Management Company
Pennsylvania
-$12.5M -268,346 Closed
Charles Schwab
38
Charles Schwab
California
-$12.3M -265,763 Closed
FTCM
39
First Trust Capital Management
Illinois
-$11.6M -250,000 Closed
N
40
Nuveen
North Carolina
-$10.4M -224,252 Closed
CM
41
Capula Management
Cayman Islands
-$9.93M -213,800 Closed
VOYA Investment Management
42
VOYA Investment Management
Georgia
-$9.76M -210,074 Closed
SB
43
Samsara BioCapital
California
-$9.42M -202,773 Closed
SCM
44
Segantii Capital Management
Hong Kong
-$9.29M -200,000 Closed
GF
45
Gabelli Funds
New York
-$8.68M -186,900 Closed
CCM
46
Crabel Capital Management
California
-$7.48M -161,082 Closed
LP
47
LMR Partners
United Kingdom
-$7.05M -151,698 Closed
E
48
Ergoteles
New York
-$6.82M -146,759 Closed
Bank of America
49
Bank of America
North Carolina
-$6.57M -141,340 Closed
FFH
50
Fairfax Financial Holdings
Ontario, Canada
-$6.04M -130,000 Closed

DICE Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in DICE Therapeutics, Inc. Common Stock (DICE) for Q3 2023, worth a combined $0 — down 100% from $2.11B a quarter earlier.

Sellers outnumbered buyers: 159 funds closed out of DICE and 0 opened new positions — a net loss of 159 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RA Capital Management, exiting entirely with an estimated $365M sold.

  • 0 institutional investors held DICE Therapeutics, Inc. Common Stock (DICE) as of Q3 2023, down from 160 in Q2 2023.
  • Funds reported $0 of DICE Therapeutics, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new DICE Therapeutics, Inc. Common Stock positions in Q3 2023 and 159 closed out, a net change of -159 holders.
  • The largest DICE Therapeutics, Inc. Common Stock seller in Q3 2023 was RA Capital Management, an estimated $365M sold.

Based on aggregated 13F filings for Q3 2023.